Fatty Liver Disease (FLD) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease
Conditions: Non-alcoholic Fatty Liver Disease; Obesity Interventions: Drug: BI 3006337; Drug: Placebo matching BI 3006337 Sponsor: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials

Diet, Immunometabolism and Non-alcoholic Fatty Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease; Liver Fat; Obesity; Inflammation Interventions: Behavioral: Standard healthy eating advice; Behavioral: eTRE plus Mediterranean diet Sponsors: University College Dublin; St. James's Hospital, Ireland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials

Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
Conditions: Fatty Liver Disease; Fatty Liver Interventions: Drug: Itopride; Drug: conventional therapy Sponsors: October 6 University; Beni-Suef University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials

Defining Circadian Metabolism in Non-alcoholic Fatty Liver Disease
Condition: NAFLD Intervention: Behavioral: Lifestyle and weight loss advice Sponsor: University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials